Condition: Head and Neck Tumor · Breast Cancer · Sponsor: The Second Affiliated Hospital of Hainan Medical University
Radiation induced dermatitis (RID) is one of the leading adverse events of radiation therapy, and if occurred could alter the course of therapy. The main pathways of RID is inflammation and oxidative stress on local and systemic bases. The Diclofenac is a COX-2 inhibitor and Nonsteroidal anti-inflammatory drugs whose anti-inflammatory and antioxidant activities have been proven in several clinical trials. Thus, the aim of the present study is to evaluate the efficacy of Diclofenac sodium gel as a prophylactic method against the development of RID.
This description comes directly from the study's public registry record.
yuecan zeng · 19946610752 · wellyy2005@hainmc.edu.cn
junnv xu · 18208946196 · xujunnv@sina.com
Always discuss trial participation with your own doctor first.
| The Second Affiliated Hospital of Hainan Medical University | Haikou, Hainan, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06905561